[S,S]-Reboxetine Long Term Safety Study In Chronic Painful Diabetic Peripheral Neuropathy.
NCT ID: NCT00348894
Last Updated: 2011-06-01
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
PHASE2
136 participants
INTERVENTIONAL
2006-07-31
2007-10-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
A Trial Of [S,S]-Reboxetine In Patients With Chronic Painful Diabetic Peripheral Neuropathy.
NCT00625833
[S,S]-Reboxetine Long Term Safety Study In Post-Shingles Pain.
NCT00354094
[S,S]-Reboxetine Dose-Range Finding Trial
NCT00288652
Study of [S,S]-Reboxetine in Patients With Postherpetic Neuralgia, Who Are Gabapentin Treatment Failures
NCT00143442
Effects of LY3848575 Versus Placebo in Participants With Painful Distal Sensory Polyneuropathy
NCT06568042
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Open Treatment
\[S,S\]-reboxetine
[S,S]-Reboxetine
\[S,S\]-reboxetine
Standard Care
Standard Care
Any
Any standard of care treatment for DPN
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
[S,S]-Reboxetine
\[S,S\]-reboxetine
Any
Any standard of care treatment for DPN
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patients at screening must have a score \>/=40 mm on the pain visual analogue scale
Exclusion Criteria
* Patients with other severe pain, that may impair the self-assessment of the pain due to DPN
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Pfizer
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Pfizer Inc
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Pfizer CT.gov Call Center
Role: STUDY_DIRECTOR
Pfizer
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Pfizer Investigational Site
Birmingham, Alabama, United States
Pfizer Investigational Site
Birmingham, Alabama, United States
Pfizer Investigational Site
Phoenix, Arizona, United States
Pfizer Investigational Site
Scottsdale, Arizona, United States
Pfizer Investigational Site
Jonesboro, Arkansas, United States
Pfizer Investigational Site
Auburn, California, United States
Pfizer Investigational Site
Huntington Beach, California, United States
Pfizer Investigational Site
Orangevale, California, United States
Pfizer Investigational Site
Naples, Florida, United States
Pfizer Investigational Site
Winter Park, Florida, United States
Pfizer Investigational Site
Honululu, Hawaii, United States
Pfizer Investigational Site
Chicago, Illinois, United States
Pfizer Investigational Site
Columbia, Missouri, United States
Pfizer Investigational Site
Jefferson City, Missouri, United States
Pfizer Investigational Site
St Louis, Missouri, United States
Pfizer Investigational Site
Omaha, Nebraska, United States
Pfizer Investigational Site
Las Vegas, Nevada, United States
Pfizer Investigational Site
Reno, Nevada, United States
Pfizer Investigational Site
Nashua, New Hampshire, United States
Pfizer Investigational Site
Syracuse, New York, United States
Pfizer Investigational Site
Greensboro, North Carolina, United States
Pfizer Investigational Site
Dallas, Texas, United States
Pfizer Investigational Site
Richmond, Virginia, United States
Pfizer Investigational Site
Tacoma, Washington, United States
Pfizer Investigational Site
Buenos Aires, , Argentina
Pfizer Investigational Site
Buenos Aires, , Argentina
Pfizer Investigational Site
Buenos Aires, , Argentina
Pfizer Investigational Site
Buenos Aires, , Argentina
Pfizer Investigational Site
Buenos Aires, , Argentina
Pfizer Investigational Site
Winnipeg, Manitoba, Canada
Pfizer Investigational Site
Ottawa, Ontario, Canada
Pfizer Investigational Site
Toronto, Ontario, Canada
Pfizer Investigational Site
Toronto, Ontario, Canada
Pfizer Investigational Site
Laval, Quebec, Canada
Pfizer Investigational Site
Montreal, Quebec, Canada
Pfizer Investigational Site
Osijek, , Croatia
Pfizer Investigational Site
Split, , Croatia
Pfizer Investigational Site
Pärnu, , Estonia
Pfizer Investigational Site
Tallinn, , Estonia
Pfizer Investigational Site
Tartu, , Estonia
Pfizer Investigational Site
Tartu, , Estonia
Pfizer Investigational Site
Viljandi Mk., , Estonia
Pfizer Investigational Site
Helsinki, , Finland
Pfizer Investigational Site
Oulu, , Finland
Pfizer Investigational Site
Seinäjoki, , Finland
Pfizer Investigational Site
Tampere, , Finland
Pfizer Investigational Site
Bad Mergentheim, , Germany
Pfizer Investigational Site
Mainz, , Germany
Pfizer Investigational Site
Meissen, , Germany
Pfizer Investigational Site
Münster, , Germany
Pfizer Investigational Site
St.Ingbert, , Germany
Pfizer Investigational Site
Tann I.d. Rhoen, , Germany
Pfizer Investigational Site
Würzburg, , Germany
Pfizer Investigational Site
Hyderabad, Andhra Pradesh, India
Pfizer Investigational Site
Bangalore, Karnataka, India
Pfizer Investigational Site
Maharashtra, Mumbai, India
Pfizer Investigational Site
Ansārinagar, New Delhi, India
Pfizer Investigational Site
Ludhiana, , India
Pfizer Investigational Site
Vellore, , India
Pfizer Investigational Site
Bytom, , Poland
Pfizer Investigational Site
Lodz, , Poland
Pfizer Investigational Site
Lublin, , Poland
Pfizer Investigational Site
Otwock, , Poland
Pfizer Investigational Site
Wroclaw, , Poland
Pfizer Investigational Site
Łask, , Poland
Pfizer Investigational Site
Moscow, , Russia
Pfizer Investigational Site
Moscow, , Russia
Pfizer Investigational Site
Saint Petersburg, , Russia
Pfizer Investigational Site
Saint Petersburg, , Russia
Pfizer Investigational Site
Johannesburg, Gauteng, South Africa
Pfizer Investigational Site
Parktown, Gauteng, South Africa
Pfizer Investigational Site
Durban, KwaZulu-Natal, South Africa
Pfizer Investigational Site
Durban, Overport, South Africa
Pfizer Investigational Site
Durban, , South Africa
Pfizer Investigational Site
Durban, , South Africa
Pfizer Investigational Site
Houghton, Johannesburg, , South Africa
Pfizer Investigational Site
Pretoria, , South Africa
Pfizer Investigational Site
Soweto, , South Africa
Pfizer Investigational Site
Gothenburg, , Sweden
Pfizer Investigational Site
Gothenburg, , Sweden
Pfizer Investigational Site
Gothenburg, , Sweden
Pfizer Investigational Site
Stockholm, , Sweden
Pfizer Investigational Site
Umeå, , Sweden
Pfizer Investigational Site
Dnipropetrovsk, , Ukraine
Pfizer Investigational Site
Donetsk, , Ukraine
Pfizer Investigational Site
Kharkiv, , Ukraine
Pfizer Investigational Site
Kyiv, , Ukraine
Pfizer Investigational Site
Odesa, , Ukraine
Pfizer Investigational Site
Carshalton, Surrey, United Kingdom
Pfizer Investigational Site
Bath, , United Kingdom
Pfizer Investigational Site
Dundee, , United Kingdom
Pfizer Investigational Site
London, , United Kingdom
Pfizer Investigational Site
Manchester, , United Kingdom
Countries
Review the countries where the study has at least one active or historical site.
Related Links
Access external resources that provide additional context or updates about the study.
To obtain contact information for a study center near you, click here.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
A6061031
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.